Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Rodes, Laetitia ^a   Saha, Shyamali ^a,b   Tomaro Duchesneau, Catherine ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CARBOXYLIC ACID; ENDOTOXIN; PROBIOTIC AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIUM LONGUM INFANTIS; CONTROLLED STUDY; ENDOTOXEMIA; ENTEROBACTERIACEAE; FISCHER 344 RAT; INTESTINE FLORA; MALE; MICROENCAPSULATION; NONHUMAN; RAT; SUPPLEMENTATION; ANIMAL; BIFIDOBACTERIUM; BLOOD; COLON; HUMAN; METABOLISM; MICROBIOLOGY; MICROFLORA;

ANIMALS; BIFIDOBACTERIUM; COLON; ENDOTOXEMIA; ENDOTOXINS; HUMANS; MALE; MICROBIOTA; RATS; RATS, INBRED F344;

EID: 84902173122     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/602832     Document Type: Article

References (48)

1. Savage D. C., Microbial ecology of the gastrointestinal tract. Annual Review of Microbiology 1977 31 107 133 2-s2.0-0017341656
2. Qin J., Li R., Raes J., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010 464 7285 59 65
3. Prakash S., Rodes L., Coussa-Charley M., Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011 5 71 86
4. Manco M., Putignani L., Bottazzo G. F., Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocrine Reviews 2010 31 6 817 844 2-s2.0-78650465542 10.1210/er.2009-0030
5. Glaros T. G., Chang S., Gilliam E. A., Causes and consequences of low grade endotoxemia and inflammatory diseases. Frontiers in Bioscience 2013 5 754 765
6. Piya M. K., Harte A. L., McTernan P. G., Metabolic endotoxaemia: is it more than just a gut feeling? Current Opinion in Lipidology 2013 24 1 78 85
7. Chang S., Li L., Metabolic endotoxemia: a novel concept in chronic disease pathology. Journal of Medical Sciences 2011 31 5 191 209 2-s2.0-80055032775
8. Miller M. A., McTernan P. G., Harte A. L., Silva N. F. D., Strazzullo P., Alberti K. G. M. M., Kumar S., Cappuccio F. P., Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis 2009 203 2 494 502 2-s2.0-62649149321 10.1016/j.atherosclerosis.2008.06.018
9. Nahra R., Dellinger R. P., Targeting the lipopolysaccharides: still a matter of debate? Current Opinion in Anaesthesiology 2008 21 2 98 104 2-s2.0-43249113488 10.1097/ACO.0b013e3282f5335c
10. Rachoin J.-S., Schorr C. A., Dellinger R. P., Targeting endotoxin in the treatment of sepsis. Sub-Cellular Biochemistry 2010 53 323 338 2-s2.0-77956628198 10.1007/978-90-481-9078-2-15
11. Kelmer G., Update on treatments for endotoxemia. Veterinary Clinics of North America: Equine Practice 2009 25 2 259 270 2-s2.0-67649544340 10.1016/j.cveq.2009.04.012
12. FAO/WHO, Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria 2001 Cordoba, Argentina FAO/WHO
13. Payne A. N., Chassard C., Zimmermann M., The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutrition and Diabetes 2011 1 7, article e12 10.1038/nutd.2011.8
14. Dias F. S., da Silva Ávila C. L., Schwan R. F., In situ inhibition of Escherichia coli isolated from fresh pork sausage by organic acids. Journal of Food Science 2011 76 9 M605 M610 2-s2.0-80955166199 10.1111/j.1750-3841.2011. 02401.x
15. Baskett R. C., Hentges D. J., Shigella flexneri inhibition by acetic acid. Infection and Immunity 1973 8 1 91 97 2-s2.0-0015837840
16. Huang C. B., Alimova Y., Myers T. M., Ebersole J. L., Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms. Archives of Oral Biology 2011 56 7 650 654 2-s2.0-79959379566 10.1016/j.archoralbio.2011.01.011
17. Fushinobu S., Unique sugar metabolic pathways of bifidobacteria. Bioscience, Biotechnology and Biochemistry 2010 74 12 2374 2384 2-s2.0-78650650902 10.1271/bbb.100494
18. Louis P., Duncan S. H., McCrae S. I., Millar J., Jackson M. S., Flint H. J., Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. Journal of Bacteriology 2004 186 7 2099 2106 2-s2.0-1642277665 10.1128/JB.186.7.2099-2106.2004 (Pubitemid 38381199)
19. Rodes L., Khan A., Paul A., Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiology and Biotechnology 2013 23 4 518 526
20. Chang T. M. S., Prakash S., Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms. Molecular Biotechnology 2001 17 3 249 260 2-s2.0-0034965972 10.1385/MB:17:3:249 (Pubitemid 32547926)
21. Rodes L., Tomaro-Duchesneau C., Saha S., Enrichment of Bifidobacterium longum subsp. infantis ATCC, 15697 within the human gut microbiota using alginate-poly-l-lysine-alginate microencapsulation oral delivery system: an in vitro analysis using a computer-controlled dynamic human gastrointestinal model. Journal of Microencapsulation 2013 2013
22. Furet J.-P., Firmesse O., Gourmelon M., Bridonneau C., Tap J., Mondot S., Doré J., Corthier G., Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiology Ecology 2009 68 3 351 362 2-s2.0-65549150087 10.1111/j.1574-6941.2009.00671.x
23. Bacchetti De Gregoris T., Aldred N., Clare A. S., Burgess J. G., Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. Journal of Microbiological Methods 2011 86 3 351 356 2-s2.0-79960648108 10.1016/j.mimet.2011.06.010
24. Payne A. N., Chassard C., Banz Y., Lacroix C., The composition and metabolic activity of child gut microbiota demonstrate differential adaptation to varied nutrient loads in an in vitro model of colonic fermentation. FEMS Microbiology Ecology 2012 80 3 608 623 2-s2.0-84858852107 10.1111/j.1574-6941. 2012.01330.x
25. Blackwood C. B., Oaks A., Buyer J. S., Phylum- and class-specific PCR primers for general microbial community analysis. Applied and Environmental Microbiology 2005 71 10 6193 6198 2-s2.0-26844559602 10.1128/AEM.71.10.6193- 6198.2005 (Pubitemid 41456918)
26. Satokari R. M., Vaughan E. E., Akkermans A. D. L., Saarela M., De Vos W. M., Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Applied and Environmental Microbiology 2001 67 2 504 513 2-s2.0-0035146181 10.1128/AEM.67.2.504-513.2001 (Pubitemid 32121335)
27. Haarman M., Knol J., Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 2005 71 5 2318 2324 2-s2.0-18444399939 10.1128/AEM.71.5.2318-2324.2005 (Pubitemid 40646972)
28. Guarner F., Requena T., Marcos A., Consensus statements from the workshop 'Probiotics and health: scientific evidence'. Nutricion Hospitalaria 2010 25 5 700 704 2-s2.0-78049257422 10.3305/nh.2010.25.5.4844
29. Tomaro-Duchesneau C., Saha S., Malhotra M., Kahouli I., Prakash S., Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells, and other biopharmaceutics: current status and future directions. Journal of Pharmaceutics 2013 2013 19 103527 10.1155/2013/103527
30. Fanaro S., Chierici R., Guerrini P., Vigi V., Intestinal microflora in early infancy: composition and development. Acta Paediatrica, International Journal of Paediatrics 2003 91 441 48 55 2-s2.0-0141942752 (Pubitemid 37239252)
31. Prakash S., Tomaro-Duchesneau C., Saha S., Probiotics for the prevention and treatment of allergies, with an emphasis on mode of delivery and mechanism of action. Current Pharmaceutical Design 2014 20 6 1025 1037
32. Zhang W., Gu Y., Chen Y., Deng H., Chen L., Chen S., Zhang G., Gao Z., Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis. European Journal of Gastroenterology and Hepatology 2010 22 12 1481 1486 2-s2.0-78349304616 10.1097/MEG.0b013e32833eb8b0
33. Cani P. D., Neyrinck A. M., Fava F., Knauf C., Burcelin R. G., Tuohy K. M., Gibson G. R., Delzenne N. M., Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007 50 11 2374 2383 2-s2.0-34848912627 10.1007/s00125-007-0791-0 (Pubitemid 47512397)
34. Ruan X., Shi H., Xia G., Xiao Y., Dong J., Ming F., Wang S., Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition 2007 23 10 754 761 2-s2.0-34548636189 10.1016/j.nut.2007.07.002 (Pubitemid 47409965)
35. Griffiths E. A., Duffy L. C., Schanbacher F. L., Qiao H., Dryja D., Leavens A., Rossman J., Rich G., Dirienzo D., Ogra P. L., In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Digestive Diseases and Sciences 2004 49 4 579 589 2-s2.0-2942717102 10.1023/B:DDAS.0000026302.92898.ae (Pubitemid 38992545)
36. Kim K. A., Gu W., Lee I. A., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 2012 7 10 e47713
37. Bryans T. D., Braithwaite C., Broad J., Cooper J. F., Darnell K. R., Hitchins V. M., Karren A. J., Lee P. S., Bacterial endotoxin testing: a report on the methods, background, data, and regulatory history of extraction recovery efficiency. Biomedical Instrumentation and Technology 2004 38 1 73 78 2-s2.0-1242352631 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2 (Pubitemid 38233288)
38. Keshavarzian A., Farhadi A., Forsyth C. B., Rangan J., Jakate S., Shaikh M., Banan A., Fields J. Z., Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. Journal of Hepatology 2009 50 3 538 547 2-s2.0-59549106331 10.1016/j.jhep.2008.10.028
39. Dehghan P., Gargari B. P., Jafar-Abadi M. A., Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-controlled clinical trial. International Journal of Food Sciences and Nutrition 2014 65 1 117 123
40. Ghanim H., Sia C. L., Upadhyay M., Korzeniewski K., Viswanathan P., Abuaysheh S., Mohanty P., Dandona P., Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. American Journal of Clinical Nutrition 2010 91 4 940 949 2-s2.0-77950488227 10.3945/ajcn.2009.28584
41. Perrin S., Warchol M., Grill J. P., Schneider F., Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium. Journal of Applied Microbiology 2001 90 6 859 865 2-s2.0-0034991622 10.1046/j.1365-2672.2001.01317.x (Pubitemid 32500232)
42. González R., Blancas A., Santillana R., Azaola A., Wacher C., Growth and final product formation by Bifidobacterium infantis in aerated fermentations. Applied Microbiology and Biotechnology 2004 65 5 606 610 2-s2.0-6944222530 10.1007/s00253-004-1603-9 (Pubitemid 39410068)
43. Wang X., Gibson G. R., Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. Journal of Applied Bacteriology 1993 75 4 373 380 2-s2.0-0027448996 (Pubitemid 23305383)
44. Osman N., Adawi D., Molin G., Ahrne S., Berggren A., Jeppsson B., Bifidobacterium infantis strains with and without a combination of Oligofructose and Inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterology 2006 6, article 31 2-s2.0-33750943795 10.1186/1471-230X-6-31 (Pubitemid 44734294)
45. Ohigashi S., Sudo K., Kobayashi D., Significant changes in the intestinal environment after surgery in patients with colorectal cancer. Journal of Gastrointestinal Surgery 2013 17 9 1657 1664
46. Ohigashi S., Sudo K., Kobayashi D., Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Digestive Diseases and Sciences 2013 58 6 1717 1726
47. Cheikhyoussef A., Cheikhyoussef N., Chen H., Zhao J., Tang J., Zhang H., Chen W., Bifidin I-a new bacteriocin produced by Bifidobacterium infantis BCRC 14602: purification and partial amino acid sequence. Food Control 2010 21 5 746 753 2-s2.0-73549095170 10.1016/j.foodcont.2009.11.003
48. Salazar N., Gueimonde M., Hernández-Barranco A. M., Ruas-Madiedo P., De Los Reyes-Gavilán C. G., Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Applied and Environmental Microbiology 2008 74 15 4737 4745 2-s2.0-49449109117 10.1128/AEM.00325-08